🎉 𝗛𝗮𝗽𝗽𝘆 𝗡𝗲𝘄 𝗬𝗲𝗮𝗿 𝗳𝗿𝗼𝗺 𝗜𝗻𝗻𝗼𝗾𝘂𝗲𝘀𝘁 𝗣𝗮𝘁𝗵𝗼𝗹𝗼𝗴𝘆! 🎉 As we welcome 2025, we are pleased to continue our partnership with your practice, delivering advanced diagnostic solutions that support the highest standards of patient care and health outcomes. At Innoquest Pathology, we recognise the critical importance of accurate diagnostics in shaping effective treatment plans and ensuring optimal patient well-being. We look forward to further strengthening our partnership with you, assisting in the achievement of your healthcare goals, and advancing the quality of care you provide to your patients. Let us work together to make this year one of sustained progress and excellence in healthcare! 📩 Sign up with us today: https://lnkd.in/gU9pc9Sk #InnoquestPathology #InnoquestMalaysia #HealthcarePartnership #PatientCare
Innoquest Pathology
Makmal Perubatan dan Diagnostik
Petaling Jaya, Selangor 2,715 pengikut
In pursuit of science, innovating for life
Perihal kami
In May 2022, Innoquest Pathology (formerly Gribbles Pathology) was officially launched. We are the only multidisciplinary clinical laboratory in Malaysia to hold both College of American Pathology (CAP) and MS ISO15189 accreditations. Supported by a deep bench of industry expertise and our ground breaking technology, Innoquest is proud to serve clinicians, hospitals, medical centres, and their patients through the deployment of advanced diagnostic testing methods and technology.
- Laman web
-
https://www.innoquest.com.my/
Pautan luaran untuk Innoquest Pathology
- Industri
- Makmal Perubatan dan Diagnostik
- Saiz syarikat
- 1,001 - 5,000 pekerja
- Ibu pejabat
- Petaling Jaya, Selangor
- Jenis
- Milik Persendirian
Lokasi
-
Utama
18A, Jalan 51A/223
2nd Floor, Wisma Tecna
Petaling Jaya, Selangor 46100, MY
Pekerja di Innoquest Pathology
-
Kuna Sabapathy
Passionate about providing best healthcare services
-
Chek Eng Mok
Marketing Head & Certified Trainer | AI-driven Social Media Strategy, Marketing Communications, Strategic Partnerships, Business Development
-
Nur Syazwani Aslin Mohd Askolan
Application Specialist
-
Fui Yuen Wong
Laboratory Management Professional with Experience in both Sales & Operation Molecular biology, Microbiology, Biochemistry in Hospital, Regional and…
Kemas Kini
-
🎄✨ 𝗔 𝗖𝗵𝗿𝗶𝘀𝘁𝗺𝗮𝘀 𝗠𝗲𝘀𝘀𝗮𝗴𝗲 𝗳𝗿𝗼𝗺 𝗜𝗻𝗻𝗼𝗾𝘂𝗲𝘀𝘁 𝗣𝗮𝘁𝗵𝗼𝗹𝗼𝗴𝘆 ✨🎄 As we come to the close of another incredible year, we want to take a moment to express our sincere gratitude to our esteemed partners. Your unwavering support and collaboration have been instrumental in our journey. At Innoquest, we are committed to delivering top-notch pathology and medical diagnostics services. We work hard to ensure our partners and patients receive the quality they deserve, and we cherish every opportunity to collaborate. As we look ahead to the new year, we are excited about the possibilities for even more fruitful partnerships. Together, we can continue to make a significant impact in the healthcare community! Wishing you all a joyous holiday season filled with love, laughter, and good health! #Innoquest #InnoquestMalaysia #HealthcarePartnerships #MedicalDiagnostics #PathologyExcellence #ChristmasGreetings #Christmas2024 #Collaboration Adam Hathsey Bronson Mathew Kuna Sabapathy June Keat Teh Hedzri P Jaafar Sumitha Bernadette Mahathevan Anand Ramachandran Ang Pei Fang Siew Loon Tham Julian Keh
-
𝗘𝘅𝗽𝗮𝗻𝗱𝗶𝗻𝗴 𝗴𝗲𝗻𝗲𝘁𝗶𝗰 𝘀𝗰𝗿𝗲𝗲𝗻𝗶𝗻𝗴 𝗰𝗮𝗽𝗮𝗯𝗶𝗹𝗶𝘁𝗶𝗲𝘀 𝘁𝗵𝗿𝗼𝘂𝗴𝗵 𝘀𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗰 𝗽𝗮𝗿𝘁𝗻𝗲𝗿𝘀𝗵𝗶𝗽 𝘄𝗶𝘁𝗵 𝗠𝗚𝗥𝗖 Innoquest Pathology Sdn Bhd is proud to announce a strategic partnership with MGRC Healthcare Sdn Bhd, enhancing our genetic screening services across Malaysia. This collaboration allows us to integrate MGRC's advanced Dtect, Origene, and Origene+PGx methodologies, expanding our reach to over 200 hospitals and 5,000 clinics. Adam Hathsey Bronson Mathew , Deputy CEO of Innoquest, emphasises the value of these screenings in providing deep insights into patients' genetic profiles for personalised health management. MGRC’s Executive Chairman, Azri Azerai , supports this synergy as a major step towards leadership in preventive medicine. Together, we're advancing personalised healthcare for a brighter future. #Innoquest #InnoquestMalaysia #HealthcareInnovation #GenomicMedicine #MGRCPartnership #PreventiveHealthcare
-
𝗧𝗿𝗮𝗻𝘀𝗳𝗼𝗿𝗺𝗶𝗻𝗴 𝗱𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰 𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲: 𝗜𝗻𝗻𝗼𝗾𝘂𝗲𝘀𝘁 𝗣𝗮𝘁𝗵𝗼𝗹𝗼𝗴𝘆 𝗹𝗮𝘂𝗻𝗰𝗵𝗲𝘀 𝗦𝗮𝗯𝗮𝗵'𝘀 𝗳𝗶𝗿𝘀𝘁 𝗱𝗶𝗴𝗶𝘁𝗮𝗹 𝗵𝗶𝘀𝘁𝗼𝗽𝗮𝘁𝗵𝗼𝗹𝗼𝗴𝘆 𝗹𝗮𝗯 Kopivosian! Innoquest Pathology is excited to announce the launch of Sabah’s first digital histopathology laboratory at Jesselton Medical Centre. As Malaysia’s only multi-disciplinary clinical lab accredited by College of American Pathology (CAP) and MS ISO 15189, we are revolutionising diagnostic healthcare with the capability to deliver results within 1-2 working days for over 400 cases monthly. Our integration of digital pathology ensures precision and efficiency in diagnosis, benefiting both patients and medical professionals. Our advanced digital pathology suite employs whole-slide imaging (WSI), enabling our team of 20 expert pathologists to analyse tissue samples with unmatched accuracy and convenience. This technology enhances diagnostic reliability, allowing pathologists to share insights and data seamlessly. By incorporating artificial intelligence and telepathology, we are poised to transform patient care through rapid, informed diagnostic decisions that profoundly impact treatment outcomes. Under the leadership of Deputy CEO East Malaysia - Borneo Ms. Kuna Sabapathy, and Innoquest Chief Pathologist Dr. Thanikachalam Pasupati Meenakshi, Innoquest is committed to advancing healthcare in East Malaysia by investing in cutting-edge technology and fostering strong collaborations. Our mission is simple: improve accessibility and quality of healthcare for the communities we serve. #Innoquest #InnoquestMalaysia #DigitalPathology #HealthcareInnovation #PathologyExcellence
-
+5
-
Onwards and upwards. Let's have a chat :)
Pathology pioneer Innoquest Pathology Malaysia is set to become a world-leading laboratory, according to ED & CEO Nabil Fawzi. #theceomagazine #inspiringthebusinessworld #leadership #business #indiasouthasia
-
𝗔 𝗷𝗼𝘆𝗼𝘂𝘀 𝗺𝗮𝗿𝗸 𝗼𝗳 𝗽𝗿𝗼𝗴𝗿𝗲𝘀𝘀 𝗮𝘁 𝗜𝗻𝗻𝗼𝗾𝘂𝗲𝘀𝘁 𝗣𝗮𝘁𝗵𝗼𝗹𝗼𝗴𝘆 On September 26, 2024, we celebrated a significant upgrade at our Johor Bahru Regional Laboratory, showcasing our commitment to enhancing healthcare services. We were thrilled to welcome our key GP clients and hospital partners, whose presence made this event even more special. ☑️𝗡𝗲𝘄𝗹𝘆 𝗿𝗲𝗳𝘂𝗿𝗯𝗶𝘀𝗵𝗲𝗱 𝗮𝗻𝗱 𝘂𝗽𝗴𝗿𝗮𝗱𝗲𝗱 𝗣𝗮𝘁𝗶𝗲𝗻𝘁 𝗖𝗲𝗻𝘁𝗿𝗲: Our Patient Centre is now more comfortable and boasts enhanced privacy features, designed to prioritise the patient experience. The newly designed landscape exemplifies our determination to offer a top-class and comfortable ambiance, now able to accommodate up to 20 patients. 𝗟𝗮𝗯 𝗲𝗻𝗵𝗮𝗻𝗰𝗲𝗺𝗲𝗻𝘁𝘀 𝗳𝗼𝗿 𝗶𝗺𝗽𝗿𝗼𝘃𝗲𝗱 𝘀𝗲𝗿𝘃𝗶𝗰𝗲𝘀: ☑️Our expanded lab space is now more systematic and well-organised, providing a much larger area to accommodate more samples efficiently. ☑️With the addition of upgraded and state-of-the-art analyser, this innovation directly enhances our sample processing efficiency and reduces turnaround time (TAT). ☑️Our newly set up microbiology lab has been expanded to ensure faster TAT and exceptional result accuracy and efficiency. Most cultures and microbiology settings can now be run with enhanced speed, delivering results effectively to our customers. The event was beautifully inaugurated with a vibrant lion dance blessing ceremony and performance, celebrating good fortune and a fresh start. Our esteemed guests, Pathology Asia’s Deputy Group CEO Nabil Fawzi and Innoquest Malaysia Deputy CEO (West Malaysia) Adam Hathsey Bronson, led the ribbon-cutting ceremony, gracing us with their presence to mark this significant milestone. Thank you to all our guests, including our valued GP clients and hospital partners, who joined us for the lab reopening launch and delightful buffet lunch. We're excited to embark on this new chapter and continue delivering exceptional care and service. Your support propels us forward in our mission of providing superior healthcare. #Innoquest #InnoquestMalaysia #MedicalInnovation #LabTechnology
-
+7
-
𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗽𝗮𝘁𝗶𝗲𝗻𝘁-𝗰𝗲𝗻𝘁𝗲𝗿𝗲𝗱 𝗰𝗮𝗻𝗰𝗲𝗿 𝗰𝗮𝗿𝗲: 𝗜𝗻𝗻𝗼𝗾𝘂𝗲𝘀𝘁 𝗣𝗮𝘁𝗵𝗼𝗹𝗼𝗴𝘆'𝘀 𝗶𝗺𝗽𝗮𝗰𝘁 𝗮𝘁 𝗧𝗿𝗮𝗻𝗦𝗠𝗲𝗖 𝟮𝟬𝟮𝟰 Breast cancer remains a critical global health issue necessitating innovative solutions. At Innoquest Pathology, we're excited to have participated in TranSMeC 2024 in Kuala Terengganu, advancing the integration of translational and holistic medicine. This collaborative approach enhances comprehensive, patient-centered care by turning scientific research into effective clinical applications while considering the patient's full health spectrum. Early detection is key, and our involvement highlighted cutting-edge tools, SPOT-MAS and OncoStrands. SPOT-MAS uses next-generation sequencing and AI for non-invasive detection of multiple cancers from a single blood draw, including breast cancer. OncoStrands personalises treatment strategies for optimal outcomes. Our booth attracted numerous healthcare professionals, buzzing with interest over our innovations while enjoying complimentary hand-crafted coffee and fresh popcorn. This underscores our commitment to pioneering healthcare solutions. Our participation concluded with a special visit to Hospital Sultan Zainal Abidin's Department of Pathology & Medical Laboratory, further cementing our dedication to collaborative advancement. Together, we are reshaping the future of patient care through early intervention and innovative partnerships. #Innoquest #InnoquestMalaysia #TranSMeC2024 #MedicalInnovation #HealthcareLeadership #BreastCancer #SPOTMAS #OncoStrands
-
+7
-
𝗘𝗹𝗲𝘃𝗮𝘁𝗶𝗻𝗴 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰 𝗣𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻: 𝗧𝗵𝗲 𝗜𝗺𝗽𝗼𝗿𝘁𝗮𝗻𝗰𝗲 𝗼𝗳 𝗕𝗹𝗼𝗼𝗱 𝗖𝘂𝗹𝘁𝘂𝗿𝗲 𝗖𝗼𝗹𝗹𝗲𝗰𝘁𝗶𝗼𝗻 Innoquest Pathology recently hosted an insightful CME training session led by Datin Dr. Ganeswarie Rajasekaram, a renowned Consultant Pathologist and Clinical Microbiologist. The session, followed by an invaluable practical demonstration from Dr. Nabil Anaz Anzani Danapaul, Clinical Consultant at Biomed Global/ BMS Diagnostics, drew an enthusiastic crowd of over 30 doctors and infection control nurses across Klang Valley hospitals, including Bukit Tinggi Medical Centre, Columbia Asia, CVSKL, KPMC Kajang, Salam and Alty Hospitals. As medical professionals, the precision in blood culture collection is paramount for diagnosing bloodstream infections accurately. This procedure is quintessential in optimising patient outcomes and minimising the risks associated with sepsis and septic shock. By focusing on reducing contamination rates, we can prevent misdiagnosis, cut unnecessary costs, and optimise antibiotic therapy efficiently. At Innoquest, we are committed to promoting the highest standards in diagnostic practices. Our relentless pursuit of excellence in infection control not only enhances clinical outcomes but fortifies patient safety. #Innoquest #InnoquestMalaysia #BloodCultureCollection #ClinicalMicrobiology #InfectionPrevention #MedicalExcellence
-
+5
-
We're #hiring a new Key Account Sales Manager in Greater Kuala Lumpur. Apply today or share this post with your network.